These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26366931)

  • 1. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
    Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
    AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
    Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
    PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
    Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
    Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
    J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
    Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
    J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.
    Imp BM; Rubin LH; Tien PC; Plankey MW; Golub ET; French AL; Valcour VG
    J Infect Dis; 2017 Jan; 215(1):114-121. PubMed ID: 27789726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
    Fourman LT; Czerwonka N; Shaikh SD; Stanley TL; Burdo TH; Williams KC; Fitch KV; Lo J; Grinspoon SK
    AIDS; 2018 Apr; 32(7):927-932. PubMed ID: 29424780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
    J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Plasma Soluble CD14 Levels Correlate with the Monocyte Response Status During Hantaan Virus Infection in Humans.
    Tang K; Zhang C; Zhang Y; Zhang Y; Zhuang R; Jin B; Ma Y
    Viral Immunol; 2015 Oct; 28(8):442-7. PubMed ID: 26196589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
    Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
    Beltrán LM; Muñoz Hernández R; de Pablo Bernal RS; García Morillo JS; Egido J; Noval ML; Ferrando-Martinez S; Blanco-Colio LM; Genebat M; Villar JR; Moreno-Luna R; Moreno JA
    PLoS One; 2014; 9(3):e90541. PubMed ID: 24594990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantity of alcohol drinking positively correlates with serum levels of endotoxin and markers of monocyte activation.
    Liangpunsakul S; Toh E; Ross RA; Heathers LE; Chandler K; Oshodi A; McGee B; Modlik E; Linton T; Mangiacarne D; Jimenez C; Dong XC; Wang L; Tu W; Nelson DE
    Sci Rep; 2017 Jun; 7(1):4462. PubMed ID: 28667254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.
    Gómez-Rial J; Currás-Tuala MJ; Rivero-Calle I; Gómez-Carballa A; Cebey-López M; Rodríguez-Tenreiro C; Dacosta-Urbieta A; Rivero-Velasco C; Rodríguez-Núñez N; Trastoy-Pena R; Rodríguez-García J; Salas A; Martinón-Torres F
    Front Immunol; 2020; 11():560381. PubMed ID: 33072099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.